Clinical Activity of REGN1979, a Bispecific Human, Anti-CD20 x Anti-CD3 Antibody, in Patients with Relapsed/Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (B-NHL)Rajat Bannerji, Max S. Topp, Jeffrey A. Barnes et al.|Blood|2019Cited by 57
REGEN-COV Antibody Combination in Outpatients With COVID-19 – Phase 1/2 ResultsThomas Norton, Shazia Ali, Sumathi Sivapalasingam et al.|medRxiv|2021Cited by 19
Virologic Efficacy of Casirivimab and Imdevimab COVID-19 Antibody Combination in Outpatients With SARS-CoV-2 InfectionCynthia Portal‐Celhay, Amber Mottola, Eduardo Forleo‐Neto et al.|JAMA Network Open|2022Cited by 17